Latest filing published 12 Sept 2023 for Bone Biologics Corp, €6,074.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -77.5%Entry US$31.78 · Close at T+365 US$7.14
- -78.6%Entry US$34.75 · Close at T+365 US$7.44
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jeff Frelick: trading record in brief
Jeff Frelick appears in our data through filings on Bone Biologics Corp shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 31 August 2023 and the latest from 11 September 2023.
The open-market record is one-sided, with 2 purchases worth €11k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The record was last updated on 12 September 2023 with an open-market purchase (€6,074) in Bone Biologics Corp. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jeff Frelick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,500 shares@ US$0.687456.8% of flowCommon StockSEC:0001493152-23-032321:0Canonical exit: 10 Dec 2023 (T+90)
- 7,600 shares@ US$0.660543.2% of flowCommon StockSEC:0001493152-23-031680:0Canonical exit: 29 Nov 2023 (T+90)
2 of 2 declarations